Treatment progress of intrahepatic cholangiocarcinoma / 国际肿瘤学杂志
Journal of International Oncology
; (12): 60-63, 2016.
Article
em Zh
| WPRIM
| ID: wpr-489661
Biblioteca responsável:
WPRO
ABSTRACT
Surgical resection is still the mainstay for treatment of intrahepatic cholangiocarcinoma (ICC).Gemcitabine and cisplatin is a systemic therapy practice standard for patients with non-resectable ICC.Neoadjuvant therapy with liver transplantation may be a new therapeutic option for patients with ICC.In addition, radiotherapy, hepatic intra-arterial therapy, ablation therapy and molecular targeted therapy are important components of comprehensive therapy for ICC.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of International Oncology
Ano de publicação:
2016
Tipo de documento:
Article